Interferon crosses blood-cerebrospinal fluid barrier in monkeys
- PMID: 1144440
- DOI: 10.3181/00379727-149-38790
Interferon crosses blood-cerebrospinal fluid barrier in monkeys
Abstract
Interferon was detected in the cerebrospinal fluid (CSF) of monkeys injected iv or im with 30 million units of human leukocyte interferon. The im injection maintained a long-lasting plateau at about 1/30th of the corresponding level of interferon in the serum. Interferon injected into the serum. Interferon injected into the cerebrospinal canal was cleared from CSF at a similar rate as it disappeared from blood after iv administration of a high dose. A relatively stable serum level was maintained for 12-24 hr after the injection of interferon into the CSF space.
Similar articles
-
Tissue distribution of human interferons after exogenous administration in rabbits, monkeys, and mice.Arch Virol. 1981;68(1):19-25. doi: 10.1007/BF01315163. Arch Virol. 1981. PMID: 6166278
-
Circulating interferon in man after administration of exogenous human leukocyte interferon.J Natl Cancer Inst. 1975 May;54(5):1045-9. J Natl Cancer Inst. 1975. PMID: 1127735
-
Pharmacokinetics of human interferon-beta in monkeys.J Interferon Res. 1981;1(3):427-36. doi: 10.1089/jir.1981.1.427. J Interferon Res. 1981. PMID: 6180075
-
The cerebrospinal fluid and barriers - anatomic and physiologic considerations.Handb Clin Neurol. 2017;146:21-32. doi: 10.1016/B978-0-12-804279-3.00002-2. Handb Clin Neurol. 2017. PMID: 29110772 Review.
-
Distribution of interferon in body fluids and tissues.Tex Rep Biol Med. 1977;35:436-42. Tex Rep Biol Med. 1977. PMID: 358467 Review. No abstract available.
Cited by
-
Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans.Antimicrob Agents Chemother. 1979 Jul;16(1):56-63. doi: 10.1128/AAC.16.1.56. Antimicrob Agents Chemother. 1979. PMID: 475375 Free PMC article.
-
Tissue distribution of human interferons after exogenous administration in rabbits, monkeys, and mice.Arch Virol. 1981;68(1):19-25. doi: 10.1007/BF01315163. Arch Virol. 1981. PMID: 6166278
-
Interferon therapy: pharmacokinetic and pharmacological aspects.Arch Virol. 1981;67(2):121-33. doi: 10.1007/BF01318595. Arch Virol. 1981. PMID: 6163417 Review. No abstract available.
-
TLR3 agonism re-establishes CNS immune competence during α4-integrin deficiency.Ann Clin Transl Neurol. 2018 Oct 30;5(12):1543-1561. doi: 10.1002/acn3.664. eCollection 2018 Dec. Ann Clin Transl Neurol. 2018. PMID: 30564621 Free PMC article.
-
Failure of interferon to modify Creutzfeldt-Jakob disease.Br Med J. 1980 Mar 29;280(6218):902. doi: 10.1136/bmj.280.6218.902-a. Br Med J. 1980. PMID: 6155969 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources